Literature DB >> 705860

The accumulation of mono-2-ethylhexylphthalate (MEHP) during storage of whole blood and plasma.

G Rock, V E Secours, C A Franklin, I Chu, D C Villeneuve.   

Abstract

The accumulation of the plasticizer di-2-ethylhexylphthalate (DEHP) in blood and blood components has been of considerable concern for some time. We have followed the accumulation of DEHP and one of its major metabolities, mono-2-ethylhexylphthalate (MEHP) during storage of whole blood, platelet-rich plasma, platelet concentrates, and platelet-poor plasma for periods ranging from 72 hours to four weeks. Both phthalates showed a progressive increase in concentration with time. While the levels of DEHP were much greater than those of MEHP, there was nonetheless a significant and continual increase in MEHP in all preparations. The highest concentrations of both DEHP and MEHP were found in the platelet-poor plasma, indicating that platelets do not have a major role in the accumulation of the phthalates in blood. The accumulation of MEHP was shown to be a direct result of the metabolism of DEHP by plasma protein(s) rather than leaching from the blood bag.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 705860     DOI: 10.1046/j.1537-2995.1978.18579036383.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

1.  An assessment of the teratogenicity in the rat and mutagenicity in Salmonella of mono-2-ethylhexyl phthalate.

Authors:  J A Ruddick; D C Villeneuve; I Chu; E Nestmann; D Miles
Journal:  Bull Environ Contam Toxicol       Date:  1981-08       Impact factor: 2.151

2.  Sub-acute and sub-chronic toxicity of mono-2-ethylhexyl phthalate in the rat.

Authors:  I Chu; V E Secours; I A Marino; D C Villeneuve; V E Valli
Journal:  Arch Environ Contam Toxicol       Date:  1981       Impact factor: 2.804

3.  Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples.

Authors:  H A Dirven; P H van den Broek; F J Jongeneelen
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Effects of co-administration of di(2-ethylhexyl)phthalate and testosterone on several parameters in the testis and pharmacokinetics of its mono-de-esterified metabolite.

Authors:  S Oishi
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

5.  Analysis of contaminants in factor VIII preparations administered to patients with hemophilia.

Authors:  G A Rock; G Farrah; G Rozon; R K Smiley; R Cole; D Villeneuve; P Tittley
Journal:  Can Med Assoc J       Date:  1983-02-15       Impact factor: 8.262

6.  Distribution of di(2-ethylhexyl) phthalate and products in blood and blood components.

Authors:  G Rock; R S Labow; M Tocchi
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

7.  Effects of prolonged administration of phthalate ester on the liver.

Authors:  A E Ganning; U Brunk; C Edlund; A Elhammer; G Dallner
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

8.  Fetotoxic effects of mono-2-ethylhexyl phthalate (MEHP) in mice.

Authors:  I Tomita; Y Nakamura; Y Yagi; K Tutikawa
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

9.  Inhibition of human platelet phospholipase A2 by mono(2-ethylhexyl)phthalate.

Authors:  R S Labow; E Meek; G A Adams; G Rock
Journal:  Environ Health Perspect       Date:  1988-06       Impact factor: 9.031

Review 10.  Overview of phthalate ester pharmacokinetics in mammalian species.

Authors:  W M Kluwe
Journal:  Environ Health Perspect       Date:  1982-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.